Guy Subra

431 total citations
24 papers, 359 citations indexed

About

Guy Subra is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Guy Subra has authored 24 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 9 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Guy Subra's work include Synthesis and Biological Evaluation (7 papers), Synthesis and biological activity (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Guy Subra is often cited by papers focused on Synthesis and Biological Evaluation (7 papers), Synthesis and biological activity (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Guy Subra collaborates with scholars based in France, United Kingdom and New Zealand. Guy Subra's co-authors include Alain Chavanieu, Jean‐François Guichou, Pierre‐Antoine Bonnet, Jean‐Pierre Chapat, Julien Viaud, Bernard Gallez, Yea‐Lih Lin, Thierry Guiberteau, J. Chambron and R. Chiarelli and has published in prestigious journals such as Journal of Medicinal Chemistry, Magnetic Resonance in Medicine and European Journal of Biochemistry.

In The Last Decade

Guy Subra

23 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy Subra France 10 132 123 72 67 45 24 359
Tsvetan G. Gantchev Canada 13 254 1.9× 89 0.7× 133 1.8× 31 0.5× 23 0.5× 27 489
Tatsuji Matsuoka Japan 11 359 2.7× 117 1.0× 47 0.7× 12 0.2× 34 0.8× 20 591
R. G. WALLACE United Kingdom 8 213 1.6× 200 1.6× 27 0.4× 48 0.7× 14 0.3× 14 527
Kevin Crowell Canada 13 364 2.8× 61 0.5× 41 0.6× 20 0.3× 64 1.4× 16 474
Simon Ruedisser Switzerland 5 165 1.3× 30 0.2× 65 0.9× 29 0.4× 70 1.6× 6 264
Kentaro Iwata Japan 9 278 2.1× 29 0.2× 89 1.2× 16 0.2× 105 2.3× 13 510
David J. Phelps Canada 11 251 1.9× 113 0.9× 34 0.5× 24 0.4× 88 2.0× 29 452
George A. Krudy United States 11 177 1.3× 101 0.8× 46 0.6× 8 0.1× 62 1.4× 21 418
Pierre Viallet France 12 235 1.8× 52 0.4× 61 0.8× 83 1.2× 66 1.5× 46 462
Dóra K. Menyhárd Hungary 15 380 2.9× 112 0.9× 98 1.4× 11 0.2× 60 1.3× 61 573

Countries citing papers authored by Guy Subra

Since Specialization
Citations

This map shows the geographic impact of Guy Subra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Subra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Subra more than expected).

Fields of papers citing papers by Guy Subra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Subra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Subra. The network helps show where Guy Subra may publish in the future.

Co-authorship network of co-authors of Guy Subra

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Subra. A scholar is included among the top collaborators of Guy Subra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Subra. Guy Subra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benod, Cindy, Guy Subra, Virginie Nahoum, et al.. (2008). N-1H-Benzimidazol-5-ylbenzenesulfonamide derivatives as potent hPXR agonists. Bioorganic & Medicinal Chemistry. 16(7). 3537–3549. 8 indexed citations
2.
Lemaire, G., Cindy Benod, Virginie Nahoum, et al.. (2007). Discovery of a Highly Active Ligand of Human Pregnane X Receptor: A Case Study from Pharmacophore Modeling and Virtual Screening to “In Vivo” Biological Activity. Molecular Pharmacology. 72(3). 572–581. 46 indexed citations
3.
Viaud, Julien, Guy Subra, Nicolas Cauquil, et al.. (2007). Structure–activity relationships of Bak derived peptides: Affinity and specificity modulations by amino acid replacement. European Journal of Medicinal Chemistry. 43(5). 966–972. 12 indexed citations
4.
Guichou, Jean‐François, Julien Viaud, Clément Mettling, et al.. (2006). Structure-Based Design, Synthesis, and Biological Evaluation of Novel Inhibitors of Human Cyclophilin A. Journal of Medicinal Chemistry. 49(3). 900–910. 45 indexed citations
5.
Duroux-Richard, Isabelle, Guy Subra, Jean‐François Guichou, et al.. (2005). Crosslinking Photosensitized by a Ruthenium Chelate as a Tool for Labeling and Topographical Studies of G-Protein-Coupled Receptors. Chemistry & Biology. 12(1). 15–24. 20 indexed citations
6.
Deleuze‐Masquéfa, Carine, Grégori Gerebtzoff, Guy Subra, et al.. (2004). Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors. Bioorganic & Medicinal Chemistry. 12(5). 1129–1139. 27 indexed citations
7.
Chavanieu, Alain, Guy Subra, Bernard Arnaud, et al.. (2002). BIGH3 (TGFBI) Arg124 mutations influence the amyloid conversion of related peptides in vitro. European Journal of Biochemistry. 269(21). 5149–5156. 29 indexed citations
8.
Subra, Guy, Carine Deleuze‐Masquéfa, Jean‐Roch Fabreguettes, et al.. (2001). Imidazo[1,2-a]quinoxalines: synthesis and cyclic nucleotide phosphodiesterase inhibitory activity. European Journal of Medicinal Chemistry. 36(3). 255–264. 22 indexed citations
9.
Pocock, Tristan, Keith Elliott, Guy Subra, et al.. (1999). New imidazo[1,2-a]pyrazine derivatives with bronchodilatory and cyclic nucleotide phosphodiesterase inhibitory activities. Bioorganic & Medicinal Chemistry. 7(6). 1059–1065. 24 indexed citations
11.
Subra, Guy, Pierre‐Antoine Bonnet, Jean‐Pierre Chapat, et al.. (1997). Interaction and translocation of cysteamine (mercaptoethylamine) with model membranes: a 15N-NMR and 1H-NMR study. European Journal of Pharmaceutics and Biopharmaceutics. 43(1). 73–81. 3 indexed citations
12.
Bonnet, Pierre‐Antoine, et al.. (1997). Nitration in the imidazo[1,2‐a]pyrazine series. Experimental and computational results. Journal of Heterocyclic Chemistry. 34(3). 701–707. 5 indexed citations
13.
Grucker, Daniel, Thierry Guiberteau, J. Chambron, et al.. (1995). Dynamic Nuclear Polarization with Nitroxides Dissolved in Biological Fluids. Journal of Magnetic Resonance Series B. 106(2). 101–109. 60 indexed citations
14.
Haverbeke, Yves Van, et al.. (1994). Relaxivity enhancement of low molecular weight nitroxide stable free radicals: Importance of structure and medium. Magnetic Resonance in Medicine. 32(1). 11–15. 29 indexed citations
15.
Subra, Guy, et al.. (1993). Synthese de la [15N]‐cysteamine. Journal of Labelled Compounds and Radiopharmaceuticals. 33(8). 711–716. 1 indexed citations
16.
Michel, A., et al.. (1989). Pharmacokinetic study of tempo carboxylic acid, a nitroxyl MRI contrast media, in control and streptozocin diabetic rats. Journal of Pharmacy and Pharmacology. 41(8). 561–563. 2 indexed citations
17.
Subra, Guy, et al.. (1988). Activité radioprotectrice chez la Souris de composés thiazolidiniques dérivés de la cystéamine et de la mercapto-2 propylamine. European Journal of Medicinal Chemistry. 23(2). 155–164. 6 indexed citations
18.
Subra, Guy, et al.. (1986). Recherche d'agents radioprotecteurs. Δ-3 Thiazolines. 21(6). 461–466. 1 indexed citations
19.
Sentenac-Roumanou, H, et al.. (1985). ChemInform Abstract: RESEARCH OF RADIOPROTECTIVE AGENTS: Δ2‐THIAZOLINES AND HOMOLOGOUS DERIVATIVES. Chemischer Informationsdienst. 16(29). 1 indexed citations
20.
Térol, A., et al.. (1981). 1H NMR structural study of 2‐phenylthiazolidine. Organic Magnetic Resonance. 17(1). 68–70. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026